Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of personalized medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Jan 19, 2021

Dr. Teresa Girolami, Founder and CEO, BelRed Internal Medicine and Co-Founder Sound Health Solutions is an internist in Washington State and on the staff at Evergreen Hospital, the first hospital in the US to identify the COVID-19 virus. She points out lessons learned about the use of ventilators, the value of testing,...


Jan 19, 2021

Dr. Teresa Girolami, Founder and CEO, BelRed Internal Medicine and Co-Founder Sound Health Solutions is an internist in Washington State and on the staff at Evergreen Hospital, the first hospital in the US to identify the COVID-19 virus. She points out lessons learned about the use of ventilators, the value of testing,...


Jan 18, 2021

Dr. Jonathan Javitt, Founder, Chairman and CEO, NeuroRx talks about drawing on their work developing novel therapeutics for bipolar depression and respiratory disease to focus on a therapy, aviptadil also known as ZYESAMI, for critical COVID-19 especially those with advanced comorbidities. This peptide hormone VIP...


Jan 18, 2021

Dr. Jonathan Javitt, Founder, Chairman and CEO, NeuroRx talks about drawing on their work developing novel therapeutics for bipolar depression and respiratory disease to focus on a therapy, aviptadil also known as ZYESAMI, for critical COVID-19 especially those with advanced comorbidities. This peptide hormone VIP...


Jan 11, 2021

Ian Chan, CEO, Abpro is developing a drug which is a COVID-19 neutralizing antibody that has demonstrated strong binding affinity for COVID-19 in a Phase 2/3 global trial. Using the Diverse Immune Platform, an advanced antibody discovery platform, Abpro is drawing on years of successful work developing neutralizing...